戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 flow obstruction, which presents as an acute Budd-Chiari syndrome.
2 e patient died at 1 month from tumor-related Budd-Chiari syndrome.
3 arcoidosis, congenital hepatic fibrosis, and Budd-Chiari syndrome.
4 e frequently the venous system, typically as Budd-Chiari syndrome.
5 atichydrothorax, portal vein thrombosis, and Budd-Chiari syndrome.
6 ic and portal veins, resulting in functional Budd-Chiari syndrome and portal hypertension.
7       TIPS has also been used as therapy for Budd-Chiari syndrome and veno-occlusive disease.
8                             In patients with Budd-Chiari syndrome and with portal vein thrombosis, Ki
9 s in patients with hepatic vein obstruction (Budd-Chiari Syndrome) and in those with portal vein thro
10 e described in the context of heart disease, Budd-Chiari syndrome, and the sinusoidal obstruction syn
11 dical records of all patients diagnosed with Budd-Chiari syndrome at the Johns Hopkins Hospital durin
12 an lead to hepatic congestion, cirrhosis and Budd-Chiari syndrome (BCS) and can predispose to develop
13 eoplasms (MPNs) are the most common cause of Budd-Chiari syndrome (BCS) and nonmalignant, noncirrhoti
14                                              Budd-Chiari syndrome (BCS) and portal vein thrombosis ha
15                                Management of Budd-Chiari syndrome (BCS) has improved over the last de
16                                              Budd-Chiari syndrome (BCS) is a rare condition associate
17                                              Budd-Chiari syndrome (BCS) is a rare, life-threatening d
18                                              Budd-Chiari syndrome (BCS) is uncommon in the children.
19 the outcome of liver transplantation (LT) in Budd-Chiari Syndrome (BCS) patients who are listed as st
20                                              Budd-Chiari Syndrome (BCS) results from obstruction to h
21 o orthotopic liver transplantation (OLT) for Budd-Chiari syndrome (BCS) traditionally have been antic
22                    Either acute or sub-acute Budd-Chiari syndrome (BCS) with diffuse occlusion of hep
23 ic shunt (TIPS) in a series of patients with Budd-Chiari syndrome (BCS), and to determine the predict
24 ive disorders (MPDs) are a frequent cause of Budd-Chiari syndrome (BCS), treatment directed toward al
25      Giant invalidating tumor (5 HAS, 1 with Budd-Chiari syndrome [BCS], and 10 supposed epithelioid
26 ngs included hepatofugal portal venous flow, Budd-Chiari syndrome, cavernous transformation of the po
27 d with autoimmune hepatitis, Wilson disease, Budd-Chiari syndrome, hepatitis B virus reactivation, in
28                                              Budd-Chiari syndrome, occlusion or obstruction of hepati